Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Mult Scler ; 21(8): 1013-24, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25680984

ABSTRACT

BACKGROUND AND OBJECTIVE: We explored which clinical and biochemical variables predict conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS) in a large international cohort. METHODS: Thirty-three centres provided serum samples from 1047 CIS cases with at least two years' follow-up. Age, sex, clinical presentation, T2-hyperintense lesions, cerebrospinal fluid (CSF) oligoclonal bands (OCBs), CSF IgG index, CSF cell count, serum 25-hydroxyvitamin D3 (25-OH-D), cotinine and IgG titres against Epstein-Barr nuclear antigen 1 (EBNA-1) and cytomegalovirus were tested for association with risk of CDMS. RESULTS: At median follow-up of 4.31 years, 623 CIS cases converted to CDMS. Predictors of conversion in multivariable analyses were OCB (HR = 2.18, 95% CI = 1.71-2.77, p < 0.001), number of T2 lesions (two to nine lesions vs 0/1 lesions: HR = 1.97, 95% CI = 1.52-2.55, p < 0.001; >9 lesions vs 0/1 lesions: HR = 2.74, 95% CI = 2.04-3.68, p < 0.001) and age at CIS (HR per year inversely increase = 0.98, 95% CI = 0.98-0.99, p < 0.001). Lower 25-OH-D levels were associated with CDMS in univariable analysis, but this was attenuated in the multivariable model. OCB positivity was associated with higher EBNA-1 IgG titres. CONCLUSIONS: We validated MRI lesion load, OCB and age at CIS as the strongest independent predictors of conversion to CDMS in this multicentre setting. A role for vitamin D is suggested but requires further investigation.


Subject(s)
Multiple Sclerosis/pathology , Adult , Cohort Studies , Disease Progression , Endonucleases , Female , Follow-Up Studies , Humans , Immunoglobulin G/analysis , Magnetic Resonance Imaging , Male , Multiple Sclerosis/cerebrospinal fluid , Nuclear Proteins/analysis , Oligoclonal Bands/genetics , Predictive Value of Tests , Prognosis , Risk Assessment , Survival Analysis , Vitamin D/blood
2.
Fortschr Neurol Psychiatr ; 82(10): 566-71, 2014 Oct.
Article in German | MEDLINE | ID: mdl-25299627

ABSTRACT

Optical coherence tomography (OCT) is a non-invasive, contact-less imaging method which provides an "in vivo" representation of the retina. It allows the quantitative measurement of retinal nerve fibre layer thickness (RNFLT) and macula thickness (MT) and, in addition, is suitable to measure volumes (e.g., macula volume/MV). In the research of neurodegenerative diseases, OCT has been increasingly used and has shown its potential as a possible diagnostic tool over the course of the last few years. In recent years, the hypothesis that mental disorders like schizophrenia or unipolar depressive disorder have a degenerative component was established through a variety of volumetric MRI studies. This review article aims to present the method of OCT, to display its recent use in medicine and psychiatry, as well as to examine possible additional applications in the field of psychiatry.


Subject(s)
Mental Disorders/diagnosis , Psychiatry/instrumentation , Tomography, Optical Coherence/methods , Humans , Macula Lutea/anatomy & histology , Macula Lutea/pathology , Mental Disorders/pathology , Retina/pathology , Retinal Neurons/pathology , Schizophrenia/diagnosis
3.
Mult Scler ; 19(9): 1209-12, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23093485

ABSTRACT

Recently, the disappearance of oligoclonal bands (OCBs) from the cerebrospinal fluid (CSF) of a few natalizumab-treated patients with multiple sclerosis (MS) has been reported. This is interesting since CSF-restricted OCB are believed to persist in MS. We pooled CSF data from 14 MS centers to obtain an adequate sample size for investigating the suspected changes in central nervous system (CNS)-restricted humoral immune activities in the context of natalizumab therapy. In a retrospective chart analysis, CSF parameters of blood-CSF barrier integrity and intrathecal IgG production from 73 natalizumab-treated MS patients requiring a diagnostic puncture for exclusion of progressive multifocal leukoencephalopathy were compared with CSF data obtained earlier in the course of disease before natalizumab therapy. At the time of repeat lumbar puncture, local IgG production (according to Reibergram) was significantly reduced (p < 0.0001) and OCB had disappeared in 16% of the patients. We therefore conclude that natalizumab therapy interferes with intrathecal antibody production at least in a significant number of patients.


Subject(s)
Antibodies, Monoclonal, Humanized/therapeutic use , Antibody Formation/drug effects , B-Lymphocytes/immunology , Immunoglobulin G/cerebrospinal fluid , Multiple Sclerosis/cerebrospinal fluid , Oligoclonal Bands/cerebrospinal fluid , Adolescent , Adult , Aged , B-Lymphocytes/drug effects , Female , Humans , Immunoglobulin G/immunology , Male , Middle Aged , Multiple Sclerosis/drug therapy , Multiple Sclerosis/immunology , Natalizumab , Oligoclonal Bands/drug effects , Oligoclonal Bands/immunology , Retrospective Studies , Young Adult
4.
Eur J Neurol ; 14(8): 923-8, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17662016

ABSTRACT

The retrospective study of a consecutive autopsy series of 1100 elderly subjects (mean age 78.3 +/- 6.8 SD years), revealed sporadic cerebral amyloid angiopathy (CAA) in 50.0% and in 95.7% of autopsy-confirmed cases of Alzheimer disease (AD). Apolipoprotein (APOE) epsilon 3/4 and epsilon 4/4 were significantly more frequent in AD than in controls, and were associated with more severe degrees of CAA. Spontaneous (non-traumatic) intracerebral hemorrhages (ICH) (excluding microbleeds and hemorrhagic infarctions) were seen in 5.4% and only in 3.3% of AD cases. CAA was found in 50.6% of brains without and in 42.4% with ICH, the latter showing a significantly higher frequency of severe degrees of CAA. ICH was related to CAA in 42.4%, whilst no such relation was seen in 57.6%. Patients with CAA were older, showed a higher frequency of clinical dementia and pathologically confirmed AD, but signs of hypertension (history and/or autopsy) occurred in 40%, compared with 80% in those with non-CAA-related ICHs. CAA-related ICH more frequently involved in cerebral lobes or hemispheres, whilst non-CAA-related ones were more often located in the basal ganglia and brainstem. The data of a lower prevalence of CAA in cases with than without ICH and of ICH with and without CAA do not support the concept that CAA represents the most important risk factor for ICH in the aged, probably because of other risk factors including hypertension.


Subject(s)
Alzheimer Disease/epidemiology , Brain/pathology , Cerebral Amyloid Angiopathy/epidemiology , Cerebral Arteries/pathology , Cerebral Hemorrhage/epidemiology , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Basal Ganglia/blood supply , Basal Ganglia/pathology , Basal Ganglia/physiopathology , Brain/blood supply , Brain/physiopathology , Brain Stem/blood supply , Brain Stem/pathology , Brain Stem/physiopathology , Cerebral Amyloid Angiopathy/genetics , Cerebral Amyloid Angiopathy/physiopathology , Cerebral Arteries/physiopathology , Cerebral Cortex/blood supply , Cerebral Cortex/pathology , Cerebral Cortex/physiopathology , Cerebral Hemorrhage/genetics , Cerebral Hemorrhage/physiopathology , Comorbidity , Disease Progression , Female , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Male , Prevalence , Retrospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL